SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
More News related to SUPG
- SuperGen to Present at Lazard Healthcare Conference on November 18, 2009
- SuperGen Presentations at AACR-NCI-EORTC
- Southwest IDEAS Conference Announces Presenting Company Lineup, Lunch Programs
- SuperGen to Present at Merriman Curhan Ford Investor Summit on November 10, 2009
- SuperGen (SUPG) Tops Q3 EPS by 8c
More News related to Press Releases
- Pergamum Appoints Jorgen Thorball as New Chairman of the Board
- Research and Markets: VMWare Jumps Forward in Backup
- Advantage Sales & Marketing Selects Reliant Solutions for Continuous Assurance of Risk Management Systems
- Operation HOPE Founder and Council Vice Chairman John Hope Bryant Issues Public Statement in Support of Financial Literacy Legislative Action Post Crisis
- Sandstorm Resources Releases Funds to Silvercrest
DUBLIN, Calif.--(BUSINESS WIRE)-- SuperGen, Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, 2009 in New York.
SuperGen's presentation will begin at 9 a.m. ET. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to the discovery and development of novel cancer therapeutics in epigenetic and cell signaling modulation. The Company develops products through biochemical and clinical proof of concept to partner for further development and commercialization. For more information about SuperGen, please visit http://www.supergen.com.
Source: SuperGen, Inc.
Related Categories
Press ReleasesStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
